Evidence map›Paper›PMID 33147854›Full record

ReviewFoods (Basel, Switzerland)2020

Biological and Pharmacological Potential of Xylitol: A Molecular Insight of Unique Metabolism.

Vishal Ahuja, Markéta Macho, Daniela Ewe, Manoj Singh, Subhasish Saha, Kumar Saurav

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Characteristics ofJournal of oral microbiology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Green Biocatalysis of Xylitol Monoferulate:Biotech (Basel (Switzerland)) · 2025
    Article
  8. Article
  9. Article
  10. Food sweeteners: Angels or clowns for human health?Current research in food science · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Vishal AhujaDepartment of Biotechnology, Himachal Pradesh University, Shimla 171005, India.ORCID 0000-0001-8982-4978
Markéta MachoLaboratory of Algal Biotechnology-Centre Algatech, Institute of Microbiology of the Czech Academy of Sciences, 37901 Třeboň, Czech Republic.
Daniela EweLaboratory of Algal Biotechnology-Centre Algatech, Institute of Microbiology of the Czech Academy of Sciences, 37901 Třeboň, Czech Republic.ORCID 0000-0002-6676-2097
Manoj SinghDepartment of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana 133207, India.
Subhasish SahaLaboratory of Algal Biotechnology-Centre Algatech, Institute of Microbiology of the Czech Academy of Sciences, 37901 Třeboň, Czech Republic.ORCID 0000-0001-5767-5285
Kumar SauravLaboratory of Algal Biotechnology-Centre Algatech, Institute of Microbiology of the Czech Academy of Sciences, 37901 Třeboň, Czech Republic.ORCID 0000-0002-7084-4204
Czech Academy of Sciences, Institute of Microbiology · CZHimachal Pradesh University · INMaharishi Markandeshwar University, Mullana · INUniversity of South Bohemia in České Budějovice · CZ

Funding

Grantová Agentura České Republiky 19-17868YMinisterstvo Školství, Mládeže a Tělovýchovy CZ.02.2.69/0.0/0.0/18_070/0010493
6 · The paper itself

Abstract

Xylitol is a white crystalline, amorphous sugar alcohol and low-calorie sweetener. Xylitol prevents demineralization of teeth and bones, otitis media infection, respiratory tract infections, inflammation and cancer progression. NADPH generated in xylitol metabolism aid in the treatment of glucose-6-phosphate deficiency-associated hemolytic anemia. Moreover, it has a negligible effect on blood glucose and plasma insulin levels due to its unique metabolism. Its diverse applications in pharmaceuticals, cosmetics, food and polymer industries fueled its market growth and made it one of the top 12 bio-products. Recently, xylitol has also been used as a drug carrier due to its high permeability and non-toxic nature. However, it become a challenge to fulfil the rapidly increasing market demand of xylitol. Xylitol is present in fruit and vegetables, but at very low concentrations, which is not adequate to satisfy the consumer demand. With the passage of time, other methods including chemical catalysis, microbial and enzymatic biotransformation, have also been developed for its large-scale production. Nevertheless, large scale production still suffers from high cost of production. In this review, we summarize some alternative approaches and recent advancements that significantly improve the yield and lower the cost of production.

Indexed as

anti-canceranti-inflammatorycardiovascular diseasesnutritive sweetenerrespiratory tract infectionxylitol

Identifiers

PMID33147854
PMCPMC7693686
OpenAlexW3094930675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.